About ABCL Dividend Returns
AbCellera Biologics Inc. (ABCL) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of ABCL over the past year?
AbCellera Biologics Inc. (ABCL) delivered a return of 39.38% over the past year. Since ABCL does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in ABCL be worth today?
A $10,000 investment in AbCellera Biologics Inc. one year ago would be worth $13,938 today, representing a gain of $3,938.
Q3Does ABCL pay dividends?
AbCellera Biologics Inc. (ABCL) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For ABCL, the total return equals the price-only return.
Q4Did ABCL beat the S&P 500?
Yes, AbCellera Biologics Inc. (ABCL) outperformed the S&P 500 by 23.93 percentage points over the past year. ABCL delivered a total return of 39.38%, compared to the S&P 500's 15.45%. This 23.93pp alpha means investors in ABCL earned more than a passive S&P 500 index fund.
Q5What is ABCL's worst drawdown?
AbCellera Biologics Inc. (ABCL) experienced a maximum drawdown of -54.94% over the past year, declining from its peak on 2025-10-08 to its trough on 2026-02-05. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is ABCL's long-term total return over 10, 20, or 30 years?
AbCellera Biologics Inc. (ABCL) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is -93.9% (-24.4% CAGR) — $10,000 would have grown to $613. Over 20 years: -93.9% total return (-13.0% CAGR) — $10,000 → $613. Over 30 years: -93.9% total return (-8.9% CAGR) — $10,000 → $613. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was ABCL's best and worst year?
AbCellera Biologics Inc.'s best calendar year was 2025 with a total return of 12.9%. Its worst year was 2021 with a total return of -63.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 76.3 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).